LifeCell's patented human tissue matrix, Alloderm®, has been successfully used in over 1 million grafts and implants to date, and a growing body of clinical evidence points to its potential use in a host of other surgical applications.
In order to improve efficiencies for our customers, distribution partners and tissue bank partners, LifeCell provides this REGULATORY/LICENSING DOCUMENTATION page to allow interested parties with regulatory responsibilities and/or the general community to access and review frequently requested documents pertaining to LifeCell certification, registrations and licensing.